Characteristic | HBV DNA < 20 IU/mL | HBV DNA ≥ 20 IU/mL | P-value T test | P-value Wilcoxon rank sum test |
(N = 64) | (N = 88) | |||
Mean (SD) age (years) | 39.6 (8.0) | 37.7 (10.4) | 0.616 | 0.288 |
Mean (SD) weight (kg) | 66.2 (9.5) | 58.8 (13.4) | 0.116 | 0.092 |
Mean (SD) BMI (kg/m2) | 23.7 (4.9) | 21.6 (4.4) | 0.184 | 0.209 |
Mean (SD) CD4 count (cells/uL) | 561.7 (504.5) | 338.8 (302.7) | 0.228 | 0.144 |
n (%) | n (%) | P-value Chi square | P-value Fisher | |
Male sex | 4 (12.5 %) | 28 (87.5 %) | 0.701 | 0.728 |
Ethnicity | 0.404 | 0.381 | ||
Akan | 6 (16.2 %) | 31 (83.8 %) | ||
Ewe | 0 (0.0 %) | 15 (100.0 %) | ||
Ga | 1 (12.5 %) | 7 (87.5 %) | ||
Other | 2 (9.5 %) | 19 (90.5 %) | ||
WHO HIV stage | 0.265 | 0.174 | ||
1 & 2 | 2 (5.1 %) | 37 (94.9 %) | ||
3 & 4 | 7 (16.3 %) | 36 (83.7 %) | ||
HBeAg positive | 0 (0.0 %) | 19 (100.0 %) | 0.083 | 0.110 |
HBeAb positive | 9 (13.6 %) | 57 (86.4 %) | 0.107 | 0.193 |
HBeAg/E Ab combination | 0.361 | 0.339 | ||
HBeAg positive/Ab negative | 0 (0.0 %) | 16 (100.0 %) | ||
HBeAg negative/Ab positive | 9 (14.3 %) | 54 (85.7 %) | ||
HBeAg negative/Ab negative | 0 (0.0 %) | 1 (100.0 %) | ||
HBeAg positive/Ab positive | 0 (0.0 %) | 3 (100.0 %) | ||
HBcIgM positive | 0 (0.0 %) | 1 (100.0 %) | 0.726 | 1.000 |
Alanine aminotransferase | 0.622 | 0.731 | ||
Normal (5–40 U/L) | 6 (12.2 %) | 43 (87.8 %) | ||
Elevated > ULN | 3 (8.8 %) | 31 (91.2 %) | ||
Aspartate aminotransferase | 0.320 | 0.473 | ||
Normal (5–50 U/L) | 7 (13.5 %) | 45 (86.5 %) | ||
Elevated > ULN | 2 (6.5 %) | 29 (93.6 %) | ||
Albumin | 0.945 | 1.000 | ||
Normal (36–50 g/L) | 4 (11.1 %) | 42 (89.4 %) | ||
Low < LLN | 5 (10.6 %) | 19 (54.3 %) |